Gold: A Primer on Commodities and Trading

Gold: A Primer on Commodities and Trading

Kanchan10/27/2025

Commodity traders believe we are in the midst of a commodities market supercycle - a period of more 6 years where commodities priced in USD are going to see significant rise in their prices. Gold and Silver are amongst the most traded precious metal commodities. In this article, we explore Gold, the most widely coveted precious metal.

GoldSilverSignalsPrecious MetalsCommoditiesTradingFutures Trading
All About Monad (MON): Generate Value From Monad Blockchain

All About Monad (MON): Generate Value From Monad Blockchain

Kanchan11/25/2025

MON is the native-token of Monad Blockchain, an EVM comatible L1,the all-new superfast 10,000 TPS blockchain making waves. Learn all about Monad Blockchain, MON tokens, and how to gain value and make money from the Monad blockchain and its native MON tokens.

cryptoBlockchaininvestmentstocksdexSignalsMonad BlockchainMON
An Intrinsic Valuation of FIGMA (NYSE:FIG)

An Intrinsic Valuation of FIGMA (NYSE:FIG)

Kanchan11/20/2025

Figma just crossed the $1bn annual revenue mark and maintains a 40% growth rate. Let's dive deep into Figma's filings and estimate an intrinstic value of the leading collaborative design platform for building meaningful products

FigmaNasdaq ListingsinvestmentfinancestocksSignalsDCF Valuation
MP Materials Valuation: A Discounted Cash Flow Approach

MP Materials Valuation: A Discounted Cash Flow Approach

Kanchan12/13/2023

MP Materials (NYSE:MP), a leading rare earth materials producer in the Western Hemisphere, has impressively grown their revenue since going public in 2020. The company recently began producing NdPr - core ingredients for manufacturing permanent magnets. In this article we approach MP Materials valuation through a discounted cash flow approach.

MPSignalsStocksMP MaterialsRare EarthValuation
Novo Nordisk DCF Valuation: Should you invest in the Ozempic and Wegovy Maker for exeptional returns?

Novo Nordisk DCF Valuation: Should you invest in the Ozempic and Wegovy Maker for exeptional returns?

Kanchan01/01/2025

Novo Nordisk briefly became Europe’s most valuable company by market cap before experiencing a sharp 60% pullback within six months. Despite the volatility, this century-old pharmaceutical leader continues to innovate across its core specialties in diabetes and blood-related disorders. The company is aggressively scaling its production capacity for high-demand treatments while investing heavily in research aimed at curing emerging diseases. Novo Nordisk’s international revenue segments and its growing online prescription platform are also delivering strong year-over-year growth. In this analysis, we break down Novo Nordisk’s fundamentals and present a full intrinsic valuation using DCF.

NVONovo NordiskDenmarkDCF ValuationSignalsIntrinsic Valuation
America's Net Investment Position with the World

America's Net Investment Position with the World

Kanchan11/11/2025

How much of American assets does the world own? How much global stocks does America own? We expand the scope of Bureau of Economic Analysis to understand America's net investment position with the world.

United States of AmericaGlobal EconomyinvestmentstockstreasuriesSignals